Purpose: To review the most important metabolic effects and clinical safety data of subthreshold micropulse diode laser (D-MPL) in diabetic macular edema (DME). Methods: Review of the literature about the mechanisms of action and role of D-MPL in DME. Results: The MPL treatment does not damage the retina and is selectively absorbed by the retinal pigment epithelium (RPE). MPL stimulates secretion of different protective cytokines by the RPE. No visible laser spots on the retina were noted on any fundus image modality in different studies, and there were no changes of the outer retina integrity. Mean central retinal sensitivity (RS) increased in subthreshold micropulse diode laser group compared to standard ETDRS photocoagulation group. Conclusions: MPL is a new, promising treatment option in DME, with both infrared and yellow wavelengths using the less aggressive duty cycle (5%) and fixed power parameters. It appears to be safe from morphologic and functional point of view in mild center involving DME.

Subthreshold laser therapy for diabetic macular edema : Metabolic and safety issues / S. Vujosevic, F. Martini, E. Convento, E. Longhin, O. Kotsafti, R. Parrozzani, E. Midena. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - 20:26(2013 Sep), pp. 3267-3271. [10.2174/09298673113209990030]

Subthreshold laser therapy for diabetic macular edema : Metabolic and safety issues

S. Vujosevic
Primo
;
2013

Abstract

Purpose: To review the most important metabolic effects and clinical safety data of subthreshold micropulse diode laser (D-MPL) in diabetic macular edema (DME). Methods: Review of the literature about the mechanisms of action and role of D-MPL in DME. Results: The MPL treatment does not damage the retina and is selectively absorbed by the retinal pigment epithelium (RPE). MPL stimulates secretion of different protective cytokines by the RPE. No visible laser spots on the retina were noted on any fundus image modality in different studies, and there were no changes of the outer retina integrity. Mean central retinal sensitivity (RS) increased in subthreshold micropulse diode laser group compared to standard ETDRS photocoagulation group. Conclusions: MPL is a new, promising treatment option in DME, with both infrared and yellow wavelengths using the less aggressive duty cycle (5%) and fixed power parameters. It appears to be safe from morphologic and functional point of view in mild center involving DME.
diabetic macular edema; diabetic retinopathy; fluorescein angiography; fundus autofluorescence; laser treatment; microperimetry; optical coherence tomography; retinal safety; subthreshold micropulse laser; diabetic retinopathy; humans; low-level light therapy; macular edema; treatment outcome
Settore MED/30 - Malattie Apparato Visivo
Settore MED/13 - Endocrinologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
CMC.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 783.11 kB
Formato Adobe PDF
783.11 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/881907
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
social impact